KST Pharma
ActiveKST Pharma has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €21k and a net result of €140. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 18% of 31527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability3▼-97
Solvency8▼-92
Growth32▼-46
Stability100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days only on tighter terms
Liquidity short (current ratio 0.35 against 2.24 in 2024), and 87.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
12.5%
Return on assets
0.1%
Age of the figures
8 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 31527 sector peers (2025).
NBB · sector comparisonPosition among 31527 sector peers
Solvency
better than 18%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-05-2026, 71 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
71 d early
2024
1 d late
2023
21 d late
2022
62 d early
2021
67 d early
2020
30 d early
2019
24 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€21k▼ 88.6%
2024 · €185k
2018: €160k
2019: €162k
2020: €81k
2021: €56k
2022: €105k
2023: €183k
2024: €185k
2018 → 2025
Total assets
€169k▼ 30.8%
2024 · €244k
2018: €226k
2019: €242k
2020: €221k
2021: €144k
2022: €240k
2023: €297k
2024: €244k
2018 → 2025
Net result
€140▼ 99.8%
2024 · €62k
2018: €26k
2019: €27k
2020: €19k
2021: €35k
2022: €50k
2023: €78k
2024: €62k
2018 → 2025
Working capital
€-96k
2024 · €53k
2018: €152k
2019: €153k
2020: €3k
2021: €-13k
2022: €-49k
2023: €37k
2024: €53k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€56k-€105k▲ 88.7%€183k▲ 73.2%€185k▲ 1.3%€21k▼ 88.6%
Operating result€45k-€60k▲ 33.5%€102k▲ 69.6%€90k▼ 11.7%€30k▼ 66.6%
Net result€35k-€50k▲ 45.3%€78k▲ 54.9%€62k▼ 20.0%€140▼ 99.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 67% below 2024 and is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €169k
Fixed assets
€117k▼ 21.0%
Current assets
€51k▼ 46.2%
Equity and liabilities €169k
Equity
€21k▼ 88.6%
Debt
€147k▲ 151%
The debt ratio rises from 24.1% to 87.5%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€61k▼
2024 · €121k
Cash flow
€31k▼
2024 · €94k
Solvency
12.5%▼
2024 · 75.9%
Current ratio
0.35▼
2024 · 2.24
Quick ratio
0.35▼
2024 · 2.24
Debt / equity
6.98▲
2024 · 0.32
ROE
0.7%▼
2024 · 33.7%
ROA
0.1%▼
2024 · 25.6%
Interest coverage
51.57▼
2024 · 65.27
Debt
€147k▲
2024 · €59k
Debt ≤ 1 year
€147k▲
2024 · €42k
Debt > 1 year
€0▼
2024 · €16k
Income taxes
€29k▲
2024 · €26k
Staff costs
€13k▲
2024 · €13k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€244k€169k▼
Fixed assets21/28€149k€117k▼
Tangible fixed assets22/27€149k€117k▼
Furniture and vehicles24€61k€40k▼
Other tangible fixed assets26€88k€77k▼
Current assets29/58€95k€51k▼
Amounts receivable within one year40/41€36k€26k▼
Trade receivables40€26k€26k=
Other amounts receivable41€10k€3▼
Cash at bank and in hand54/58€55k€22k▼
Deferred charges and accrued income490/1€4k€4k▼
Equity and liabilities
Total equity and liabilities10/49€244k€169k▼
Equity10/15€185k€21k▼
Contributions10/11€19k€19k=
Reserves13€2k€2k=
Distributable reserves133€2k€2k=
Profit (loss) carried forward14€165k€652▼
Amounts payable17/49€59k€147k▲
Amounts payable after more than one year17€16k€0▼
Financial debts170/4€16k€0▼
Amounts payable within one year42/48€42k€147k▲
Current portion of amounts payable after more than one year42€18k€16k▼
Trade debts44€8k€10k▲
Suppliers440/4€8k€10k▲
Taxes, remuneration and social security45€17k€17k▲
Taxes450/3€15k€16k▲
Remuneration and social security454/9€1k€2k▲
Other amounts payable47/48€0€104k▲
Accrued charges and deferred income492/3€0-
Income statement
Code20242025
Remuneration, social security and pensions62€13k€13k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€31k€31k▼
Other operating charges640/8€387€41k▲
Gross operating margin9900€134k€116k▼
Operating profit (loss)9901€90k€30k▼
Financial income75/76B€0€0▼
Recurring financial income75€0€0▼
Financial charges65/66B€2k€1k▼
Recurring financial charges65€2k€1k▼
Profit (loss) for the period before taxes9903€88k€29k▼
Income taxes67/77€26k€29k▲
Profit (loss) for the period9904€62k€140▼
Profit (loss) for the period to be appropriated9905€62k€140▼
Appropriation of the result
Profit (loss) to be appropriated9906€225k€165k▼
Profit (loss) brought forward from the previous period14P€162k€165k▲
Profit to be distributed694/7€60k€164k▲
Return on contributions (dividend)694€60k€164k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-07
State Gazette act
General meeting · Director resignation
Permanent representative · Director appointment
28-07
State Gazette act
Board meeting · General meeting
Director appointment · Permanent representative
21-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €140 ▼99.8%
Net result drops to €140, the lowest in the series.
01-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 1 day late
2024
21-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 21 days late
2023
31-12
Financial
Highest result since 2018net €78k ▲54.9%
Operating result €102k, net result €78k, both a record.
31-12
Financial
Liquidity quadruplescurrent ratio 1.46
Current ratio from 0.41 to 1.46; short-term debt falls from €83k to €80k.
31-12
Financial
Equity above €150kEq €183k ▲73.2%
6 profitable years in a row build equity to €183k.
30-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €100kEq €105k ▲88.7%
5 profitable years in a row build equity to €105k.
25-05
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
01-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
24-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 24 days late
2019
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 27 days late
2018
28-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 28 days late
2017
22-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 22 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beloeil · 1 establishment unit since 2016
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Chaussée Brunehaut (Que) 1427972 BeloeilGround area
637 m²
Building footprint
147 m²
Volume, LiDAR
1,098 m³
Parcel 51050B0232/00P000, Wallonia · tallest building 9.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
KST Pharma
since 20162.251.076.426
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 51050B0232/00P000 | Wallonia | 637 m² | 1 · 147 m² | 9.0 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Connections & network
3 connected companiesNetwork connections
Shared director
→
Shared director
→
Shared director
→
Ownership & control
2 partiesKST PharmaBE 0647.823.210
controls
Where this company holds controlthis company sits on their board2
8 locations
1 location
Recognitions · licences · registrations
Legal Entity Identifier
254900NTVAPQ879P7732
Similar companies · same sector, comparable size
COADSH
BE 0654.866.794
Waterloo · Eq €21k
GIELISSEN
BE 0819.142.135
Londerzeel · Eq €21k
MANCO
BE 0883.337.230
Lier · Eq €21k
NPM Services
BE 0804.547.692
Kapelle-op-den-Bos · Eq €21k
PNG
BE 0467.559.893
Brasschaat · Eq €21k
Of 82,241 companies in sector 70200 we hold annual accounts for 52,386. 31,043 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-02-2016
Fiscal year end31-12
Activities, NACEBEL
70200Business and other management consultancy
70220Business consulting
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.